Lilly’s Olmorasib Gets US FDA’s Breakthrough Therapy Status For Multi-Purpose Cancer Drug
Lilly’s Olmorasib Gets US FDA’s Breakthrough Therapy Status For Multi-Purpose Cancer Drug
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.